TCM
Timpani Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-27,112
| Closed | -$3.68M | – | 103 |
|
|
2018
Q4 | $3.68M | Buy |
27,112
+707
| +3% | +$95.9K | 2.06% | 11 |
|
|
2018
Q3 | $7.25M | Sell |
26,405
-2,456
| -9% | -$674K | 2.09% | 12 |
|
|
2018
Q2 | $5.98M | Buy |
28,861
+6,562
| +29% | +$1.36M | 1.77% | 13 |
|
|
2018
Q1 | $3.68M | Sell |
22,299
-131
| -0.6% | -$21.6K | 1.29% | 30 |
|
|
2017
Q4 | $3.07M | Sell |
22,430
-12,694
| -36% | -$1.74M | 1.11% | 38 |
|
|
2017
Q3 | $4.78M | Buy |
35,124
+3,690
| +12% | +$502K | 1.74% | 15 |
|
|
2017
Q2 | $3.82M | Buy |
31,434
+16,346
| +108% | +$1.98M | 1.42% | 26 |
|
|
2017
Q1 | $1.6M | Sell |
15,088
-9,800
| -39% | -$1.04M | 0.64% | 68 |
|
|
2016
Q4 | $2.53M | Sell |
24,888
-46,674
| -65% | -$4.74M | 1.05% | 36 |
|
|
2016
Q3 | $7.3M | Buy |
71,562
+4,083
| +6% | +$417K | 2.9% | 2 |
|
|
2016
Q2 | $8.05M | Buy |
67,479
+96
| +0.1% | +$11.5K | 3.41% | 2 |
|
|
2016
Q1 | $7.22M | Sell |
67,383
-777
| -1% | -$83.2K | 3.05% | 1 |
|
|
2015
Q4 | $7.39M | Buy |
68,160
+36,771
| +117% | +$3.99M | 3% | 2 |
|
|
2015
Q3 | $2.69M | Sell |
31,389
-41,663
| -57% | -$3.57M | 1.08% | 38 |
|
|
2015
Q2 | $7.37M | Sell |
73,052
-14,080
| -16% | -$1.42M | 2.14% | 7 |
|
|
2015
Q1 | $6.72M | Sell |
87,132
-1,979
| -2% | -$153K | 2% | 9 |
|
|
2014
Q4 | $4.74M | Buy |
89,111
+47,639
| +115% | +$2.54M | 1.86% | 12 |
|
|
2014
Q3 | $1.95M | Sell |
41,472
-68,834
| -62% | -$3.23M | 0.89% | 46 |
|
|
2014
Q2 | $6.87M | Buy |
110,306
+14,953
| +16% | +$931K | 3.08% | 3 |
|
|
2014
Q1 | $6.41M | Sell |
95,353
-3,603
| -4% | -$242K | 3.39% | 1 |
|
|
2013
Q4 | $5.21M | Buy |
98,956
+20,375
| +26% | +$1.07M | 2.59% | 4 |
|
|
2013
Q3 | $3.4M | Sell |
78,581
-29,173
| -27% | -$1.26M | 2% | 16 |
|
|
2013
Q2 | $4.03M | Buy |
+107,754
| New | +$4.03M | 2.56% | 5 |
|